First Time Loading...
C

China Isotope & Radiation Corp
HKEX:1763

Watchlist Manager
China Isotope & Radiation Corp
HKEX:1763
Watchlist
Price: 10.96 HKD -0.72% Market Closed
Updated: May 4, 2024

China Isotope & Radiation Corp
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

China Isotope & Radiation Corp
Cost of Revenue Peer Comparison

Comparables:
1066
S
600529
603658
300888
300832

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
C
China Isotope & Radiation Corp
HKEX:1763
Cost of Revenue
-¥3.2B
CAGR 3-Years
-24%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Cost of Revenue
-¥6.6B
CAGR 3-Years
-9%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
S
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Cost of Revenue
-¥3.6B
CAGR 3-Years
-22%
CAGR 5-Years
-16%
CAGR 10-Years
-13%
Autobio Diagnostics Co Ltd
SSE:603658
Cost of Revenue
-¥1.7B
CAGR 3-Years
-15%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Cost of Revenue
-¥6.3B
CAGR 3-Years
-41%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Cost of Revenue
-¥1.1B
CAGR 3-Years
-28%
CAGR 5-Years
-32%
CAGR 10-Years
N/A

See Also

What is China Isotope & Radiation Corp's Cost of Revenue?
Cost of Revenue
-3.2B CNY

Based on the financial report for Dec 31, 2023, China Isotope & Radiation Corp's Cost of Revenue amounts to -3.2B CNY.

What is China Isotope & Radiation Corp's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-27%

Over the last year, the Cost of Revenue growth was -20%. The average annual Cost of Revenue growth rates for China Isotope & Radiation Corp have been -24% over the past three years , -27% over the past five years .